# SElf-SAMpling in Cervical Cancer Screening; SESAM Study

> **NCT02945891** · NA · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 310 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DEVICE:** HPV testing of Evalyn®Brush, FloqSwab and Colli-Pee specimens

## Key facts

- **NCT ID:** NCT02945891
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2017-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02945891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02945891, "SElf-SAMpling in Cervical Cancer Screening; SESAM Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02945891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*